JANX Financials

Janux Therapeutics Inc - Financial statements & key metrics

Stock Price

$15.24

Market Cap

$906.39M

EPS

$-1.83

Income Statement Highlights

Most Recent Quarter: 2024-12-31

Revenue

Gross Profit

Operating Income

Net Income

$-68.99M

EPS (Diluted)

$-1.28

Balance Sheet Highlights

Total Assets

$1.06B

Total Liabilities

$38.73M

Shareholders Equity

Cash & Equivalents

$430.61M

Total Debt

Cash Flow Highlights

Operating Cash Flow

$-43.81M

CapEx

Free Cash Flow

Profitability Metrics

Gross Margin

-1159.0%

Operating Margin

-15.8%

ROE

-0.1%

View Complete Financial Statements

Full income statements, balance sheets, and cash flows for multiple periods

Open Full Financials

Frequently Asked Questions

What is JANX revenue?

View JANX's income statement for detailed revenue data.

Is JANX profitable?

JANX reported a loss of $68.99M in the most recent quarter.

What is JANX market cap?

JANX has a market capitalization of $906.39M, making it a small-cap stock.

Does JANX have debt?

View JANX's balance sheet for debt information.

What is JANX cash flow?

Cash flow data is available in the full financial statements.